These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39251139)

  • 1. In-situ nanoplatform with synergistic neutrophil intervention and chemotherapy to prevent postoperative tumor recurrence and metastasis.
    Zheng W; Li J; Li J; Bie N; Wei Z; Qin J; Li S; Yong T; Du Q; Yang X; Gan L
    J Control Release; 2024 Nov; 375():316-330. PubMed ID: 39251139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable electrospun nanofibrous platform integrating antiplatelet therapy-chemotherapy for preventing postoperative tumor recurrence and metastasis.
    Li J; Li J; Yao Y; Yong T; Bie N; Wei Z; Li X; Li S; Qin J; Jia H; Du Q; Yang X; Gan L
    Theranostics; 2022; 12(7):3503-3517. PubMed ID: 35547751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pH-sensitive nanotherapeutic system based on a marine sulfated polysaccharide for the treatment of metastatic breast cancer through combining chemotherapy and COX-2 inhibition.
    Zhang T; Liu H; Li Y; Li C; Wan G; Chen B; Li C; Wang Y
    Acta Biomater; 2019 Nov; 99():412-425. PubMed ID: 31494294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
    Ahmed KS; Shan X; Mao J; Qiu L; Chen J
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
    Zhuang B; Chen T; Xiao Z; Jin Y
    Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioinspired doxorubicin-carried albumin Nanocage against aggressive Cancer via systemic targeting of tumor and lymph node metastasis.
    Iqbal H; Razzaq A; Liu F; Zhang F; Tao J; Li T; Jiang Y; Zhao Z; Qin M; Lin X; Ke H; Chen H; Deng Y
    J Control Release; 2024 Aug; 372():829-845. PubMed ID: 38964471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-responsive oxygen self-sufficient smart nanoplatform for enhanced tumor chemotherapy and photodynamic therapy.
    Liu X; Wang X; Zang D; Chang Y; Su W; Li G; Zhang J; Yang P; Ma X; Guo Y
    J Colloid Interface Sci; 2024 Dec; 675():1080-1090. PubMed ID: 39018635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted doxorubicin-loaded core-shell copper peroxide-mesoporous silica nanoparticles for combination of ferroptosis and chemotherapy of metastatic breast cancer.
    Nourollahian T; Taghavi S; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
    Int J Pharm; 2024 Sep; 662():124487. PubMed ID: 39029634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
    Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
    Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Injectable Chitosan-based Co-cross-linking Hydrogel for Local Delivery of
    Huang FJ; Hung CC; Chang CW; Chao JH; Hsieh BT
    Anticancer Res; 2018 Aug; 38(8):4651-4659. PubMed ID: 30061232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer.
    Park J; Park J; Castanares MA; Collins DS; Yeo Y
    Mol Pharm; 2019 May; 16(5):1864-1873. PubMed ID: 30916974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
    Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes.
    Yuan Z; Zhao X; Wang X; Qiu W; Chen X; Zheng Q; Cui W
    Int J Clin Exp Pathol; 2014; 7(9):5436-49. PubMed ID: 25337186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.
    Salehi Khesht AM; Karpisheh V; Sahami Gilan P; Melnikova LA; Olegovna Zekiy A; Mohammadi M; Hojjat-Farsangi M; Majidi Zolbanin N; Mahmoodpoor A; Hassannia H; Aghebati-Maleki L; Jafari R; Jadidi-Niaragh F
    Int J Biol Macromol; 2021 Sep; 186():849-863. PubMed ID: 34245737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies.
    Helmi O; Elshishiny F; Mamdouh W
    Int J Biol Macromol; 2021 Aug; 184():325-338. PubMed ID: 34119547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil Extracellular Traps-Inhibiting and Fouling-Resistant Polysulfoxides Potently Prevent Postoperative Adhesion, Tumor Recurrence, and Metastasis.
    Wang J; Wang Y; Li J; Ying J; Mu Y; Zhang X; Zhou X; Sun L; Jiang H; Zhuo W; Shen Y; Zhou T; Liu X; Zhou Q
    Adv Mater; 2024 Aug; 36(31):e2400894. PubMed ID: 38636448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.